Company Filing History:
1 out of 67 
1 out of 104 
Years Active: 2007
Title: Jacobus Aj Den Hartog: Innovator in S1P Modulation
Introduction
Jacobus Aj Den Hartog is a notable inventor based in the Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the S1P receptor. His work focuses on addressing cognitive disorders and age-related cognitive decline.
Latest Patents
Jacobus Aj Den Hartog holds a patent for "Fused Heterocyclic Derivatives As S1P Modulators." This invention relates to a fused heterocyclic derivative of the formula (I), where the variables R1-R4, z, A, Q, X, and Y are defined in the claims. The compounds of formula (I) are recognized as modulators of the S1P receptor, specifically acting as agonists of S1P5. These compounds have therapeutic applications in treating cognitive disorders, age-related cognitive decline, and dementia. He currently has 1 patents.
Career Highlights
Throughout his career, Jacobus has worked with prominent companies in the pharmaceutical industry, including AbbVie B.V. and AbbVie Inc. His expertise in the field has allowed him to contribute to innovative research and development projects.
Collaborations
Jacobus has collaborated with notable professionals in his field, including Pieter Smid and Wouter I Iwema Bakker. These collaborations have further enhanced his research and development efforts.
Conclusion
Jacobus Aj Den Hartog is a distinguished inventor whose work in S1P modulation has the potential to impact the treatment of cognitive disorders significantly. His contributions to medicinal chemistry continue to pave the way for future innovations in this critical area of healthcare.